Skip to main content
. Author manuscript; available in PMC: 2007 Jul 1.
Published in final edited form as: Histopathology. 2006 Jul;49(1):66–74. doi: 10.1111/j.1365-2559.2006.02470.x

Table 1.

Scoring the intensity of extracellular superoxide dismutase (ECSOD) immunoreactivity in patients with usual interstitial pneumonia (UIP)

Mast cells Alveolar macrophages Bronchial cells Epithelial endothelium Type II pneumocytes
1 +++ ++ NA ++ ++
2 +++ ++ + ++ +
3 ++ + ++ + ++
4 ++ ++ + + +
5 ++ + + + +
6 +++ + ++ ++ ++
7 +++ ++ ++ ++ ++
8 +++ ++ + ++ ++
9 +++ ++ + ++ ++
10 +++ ++ + ++ ++

NA, Not present; −, negative; +, weak immunoreactivity; ++, moderate immunoreactivity; +++, intense immunoreactivity.

Note: fibroblast foci and old fibrotic lesions were mainly negative for ECSOD immunoreactivity.

HHS Vulnerability Disclosure